Preventive Effect of Rifampicin on Alzheimer Disease Needs at Least 450 mg Daily for 1 Year: An FDG-PET Follow-Up Study

Publisher： Karger

E-ISSN： 1664-5464|7|2|204-214

ISSN： 1664-5464

Source： Dementia and Geriatric Cognitive Disorders Extra, Vol.7, Iss.2, 2017-06, pp. : 204-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neural Correlates of Stroop Performance in Alzheimer’s Disease: A FDG-PET Study

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-07 ,pp. : 190-201

Karger

Access to resources Recommend Favorite

Neural Correlates of the Clock Drawing Test Performance in Alzheimer’s Disease: A FDG-PET Study

Dementia and Geriatric Cognitive Disorders, Vol. 26, Iss. 4, 2008-10 ,pp. : 306-313

Karger

Access to resources Recommend Favorite

Depressive Symptoms in Alzheimer’s Disease and Lewy Body Dementia: A One-Year Follow-Up Study

Dementia and Geriatric Cognitive Disorders, Vol. 32, Iss. 2, 2011-10 ,pp. : 143-149

Karger

Access to resources Recommend Favorite

A 2-Year Follow-Up of Behavioural and Psychological Symptoms in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders, Vol. 11, Iss. 3, 2000-04 ,pp. : 147-152

Karger

Access to resources Recommend Favorite

Predictive Accuracy of MCI Subtypes for Alzheimer’s Disease and Vascular Dementia in Subjects with Mild Cognitive Impairment: A 2-Year Follow-Up Study

Dementia and Geriatric Cognitive Disorders, Vol. 19, Iss. 2-3, 2005-02 ,pp. : 113-119

Karger

Access to resources Recommend Favorite